These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31642959)

  • 1. Pharmacokinetics of cefoperazone/sulbactam in plasma and cerebrospinal fluid in patients with intraventricular hemorrhage after external ventricular drains.
    Meng L; Kong L; Wu C; Qi B; Wu X
    Eur J Clin Pharmacol; 2020 Jan; 76(1):127-129. PubMed ID: 31642959
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulbactam-containing beta-lactamase inhibitor combinations.
    Akova M
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():185-8. PubMed ID: 18154545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence study of the two 1.5 g cefoperazone and sulbactam IM injections in Thai healthy male volunteers.
    Kaewvichit S; Yotsawimonwat S; Taesotikul W; Niwatananun W; Duangrat C; Wongsinsup C; Thongsawat S; Salee P
    J Med Assoc Thai; 2008 Nov; 91(11):1760-4. PubMed ID: 19127801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of impaired renal function on the pharmacokinetics of coadministered cefoperazone and sulbactam.
    Rho JP; Castle S; Smith K; Bawdon RE; Norman DC
    J Antimicrob Chemother; 1992 Jun; 29(6):701-9. PubMed ID: 1506350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysis.
    Johnson CA; Zimmerman SW; Reitberg DP; Whall TJ; Leggett JE; Craig WA
    Antimicrob Agents Chemother; 1988 Jan; 32(1):51-6. PubMed ID: 3348613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple-dose pharmacokinetics and toleration of intravenously administered cefoperazone and sulbactam when given as single agents or in combination.
    Reitberg DP; Whall TJ; Chung M; Blickens D; Swarz H; Arnold J
    Antimicrob Agents Chemother; 1988 Jan; 32(1):42-6. PubMed ID: 3348612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients.
    Schwartz JI; Jauregui LE; Bachmann KA; Martin ME; Reitberg DP
    Antimicrob Agents Chemother; 1988 May; 32(5):730-5. PubMed ID: 3395103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The penetration of cefoperazone and sulbactam into the lumbar intervertebral discs.
    Köroğlu A; Acar O; Ustün ME; Tiraş B; Eser O
    J Spinal Disord; 2001 Oct; 14(5):453-4. PubMed ID: 11586148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.
    Gao C; Tong J; Yu K; Sun Z; An R; Du Z
    Eur J Clin Pharmacol; 2016 Jul; 72(7):823-30. PubMed ID: 27023465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state pharmacokinetics of cefoperazone and sulbactam in patients with acute appendicitis.
    Danziger LH; Piscitelli SC; Occhipinti DJ; Resnick DJ; Rodvold KA
    Ann Pharmacother; 1994 Jun; 28(6):703-7. PubMed ID: 7919553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of cefoperazone and sulbactam in plasma and its application to a pharmacokinetic study.
    Zhou Y; Zhang J; Guo B; Yu J; Shi Y; Wang M; Zhang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(30):3119-24. PubMed ID: 20971044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients.
    Muder RR; Agarwala S; Mirani A; Gayowski T; Venkataramanan R
    J Clin Pharmacol; 2002 Jun; 42(6):644-50. PubMed ID: 12043952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transfer of injected sulbactam/cefoperazone into burn blister fluid].
    Aoyama H; Sugiyama H; Tada M; Okuda J; Izawa Y
    Jpn J Antibiot; 1988 Sep; 41(9):1279-84. PubMed ID: 3241326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone/sulbactam after craniotomy.
    Wang Q; Wu Y; Chen B; Zhou J
    BMC Anesthesiol; 2015; 15():33. PubMed ID: 25798070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cefoperazone plus sulbactam with clindamycin plus gentamicin as treatment for intra-abdominal infections.
    Greenberg RN; Cayavec P; Danko LS; Bowen K; Montazemi R; Kearney PA; Johnson SB; Strodel WE
    J Antimicrob Chemother; 1994 Sep; 34(3):391-401. PubMed ID: 7829413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sulperazone--a combined form of cefoperazone with sulbactam].
    Iakovlev VP
    Antibiot Khimioter; 1995 Feb; 40(2):55-70. PubMed ID: 7605145
    [No Abstract]   [Full Text] [Related]  

  • 17. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
    Suzuki K; Horiba M
    Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern possibilities of hepacef combi (cefoperazon/sulbactam) application for the treatment of surgical infection].
    Herych ID; Vashchuk VV
    Klin Khir; 2011 Feb; (2):65-9. PubMed ID: 21548334
    [No Abstract]   [Full Text] [Related]  

  • 19. [The reliability of using impenem, meropenem, cefoperazone-sulbactam and piperacillin-tazobactam to treat nosocomial Gram-negative bacterial infections with Monte Carlo simulation].
    Xiao YH; Hu YJ
    Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):595-600. PubMed ID: 28789493
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro antibiotic release from poly(3-hydroxybutyrate-co-3-hydroxyvalerate) rods.
    Gurselt I; Yagmurlu F; Korkusuz F; Hasirci V
    J Microencapsul; 2002; 19(2):153-64. PubMed ID: 11837970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.